Bioactivated Glucoraphanin Improves Cell Survival, Upregulating Phospho-AKT, and Modulates Genes Involved in DNA Repair in an In Vitro Alzheimer’s Disease Model: A Network-Transcriptomic Analysis
Nutrients · 05.12.2024 · 16 (23) · 4202
DOI: 10.3390/nu16234202 ↗Kurz gefasst
Fachartikel in der Zeitschrift Nutrients, online erschienen am 05.12.2024. Verfasst von Aurelio Minuti und 4 weiteren Autor:innen. Beteiligte Einrichtung: IRCCS Centro Neurolesi "Bonino-Pulejo", Via Provinciale Palermo, Contrada Casazza, 98124 Messina, Italy. Hauptthemen laut MEDLINE: Alzheimer Disease, Sulfoxides, Cell Survival, DNA Repair. Die Arbeit wurde bisher 9-mal zitiert (Crossref) und nennt 104 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Ministero della Salute, Current Research Funds 2024, Ministry of Health, Italy.
Themen: Demenz
Abstract (Originalsprache)
Background/Objectives: Alzheimer’s disease (AD) is one of the most common neurodegenerative diseases, for which a definitive cure is still missing. Recently, natural compounds have been investigated for their possible neuroprotective role, including the bioactivated product of glucoraphanin (GRA), the sulforaphane (SFN), which is highly rich in cruciferous vegetables. It is known that SFN alleviates neuronal dysfunction, apoptosis, and oxidative stress in the brain. In the light of this evidence, the aim of this study was to investigate the molecular effects of SFN pre-treatment in differentiated SH-SY5Y neurons exposed to β-amyloid (Aβ).
Methods
To this end, we first evaluated first cell viability via the Thiazolyl Blue Tetrazolium Bromide (MTT) assay, and then we analyzed the transcriptomic profiles by next-generation sequencing (NGS). Finally, we used a network analysis in order to understand which biological processes are affected, validating them by Western blot assay.
Results
SFN pre-treatment counteracted Aβ-induced loss of cell viability. The network-transcriptomic analysis revealed that SFN upregulates genes associated with DNA repair, such as ABRAXAS1, BRCA1, BRCA2, CDKN1A, FANCA, FANCD2, FANCE, NBN, and XPC. Finally, SFN also increased the phosphorylation of AKT, which is associated with DNA repair and cell survival.
Conclusions
These data suggest that SFN is a natural compound that could be suitable in the prevention of AD, thanks to its neuroprotective role in increasing cell survival, potentially restoring DNA damage induced by Aβ exposure.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- IRCCS Centro Neurolesi "Bonino-Pulejo", Via Provinciale Palermo, Contrada Casazza, 98124 Messina, Italy.
- Department of Innovative Technologies in Medicine & Dentistry, University “G. d’Annunzio” Chieti-Pescara, Via dei Vestini, 31, 66100 Chieti, Italy.
- Department of Food Quality and Nutrition, Research and Innovation Centre, Fondazione Edmund Mach (FEM), Via E. Mach 1, 38098 San Michele all'Adige, Italy.
ORCID-Profile: Aurelio Minuti, Luigi Chiricosta, Osvaldo Artimagnella
Förderung
- Ministero della Salute
- Current Research Funds 2024, Ministry of Health, Italy
Zitieren
APA
Minuti, A., Mazzon, E., Iori, R., Chiricosta, L., & Artimagnella, O. (2024). Bioactivated Glucoraphanin Improves Cell Survival, Upregulating Phospho-AKT, and Modulates Genes Involved in DNA Repair in an In Vitro Alzheimer’s Disease Model: A Network-Transcriptomic Analysis. Nutrients, 16(23), 4202. https://doi.org/10.3390/nu16234202
Vancouver
Minuti A, Mazzon E, Iori R, Chiricosta L, Artimagnella O. Bioactivated Glucoraphanin Improves Cell Survival, Upregulating Phospho-AKT, and Modulates Genes Involved in DNA Repair in an In Vitro Alzheimer’s Disease Model: A Network-Transcriptomic Analysis. Nutrients. 2024;16(23):4202. doi:10.3390/nu16234202
BibTeX
@article{Minuti2024,
author = {Minuti, Aurelio and Mazzon, Emanuela and Iori, Renato and Chiricosta, Luigi and Artimagnella, Osvaldo},
title = {Bioactivated Glucoraphanin Improves Cell Survival, Upregulating Phospho-AKT, and Modulates Genes Involved in DNA Repair in an In Vitro Alzheimer’s Disease Model: A Network-Transcriptomic Analysis},
journal = {Nutrients},
year = {2024},
volume = {16},
number = {23},
pages = {4202},
doi = {10.3390/nu16234202}
}
EUVIMED